Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts Eye and Ear Infirmary
The purpose of this research study is to determine if early treatment using Restasis eye drops can prevent the development or delay the progression of dry eye syndrome in allogeneic bone marrow transplant (BMT) recipients.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female
At least 18 years of age
Approved candidate for allogeneic HSCT
Ability to understand and provide informed consent to participate in this study
Willingness to follow study instructions and likely to complete all required visits
You may not be if
History of ocular or eyelid surgery
History of glaucoma or ocular hypertension
History of herpetic eye disease
Patient with acne rosacea, blepharitis, or meibomitis, in the opinion of the investigator
Any ocular disorder or condition (including ocular infection, trauma, and disease) that could possibly interfere with the interpretation of the study results
Recent (3-month) history of wearing contact lens
Anticipated contact lens wear during any portion of the study
Recent (3-month) history of current use of topical steroids or antiglaucoma agents
Any punctal occlusion within 2 months of the screening visit
History of connective tissue disease or diabetes
Any condition (including language barrier) that precludes patient's ability to comply with study requirements including completion of study
Clareo Health | The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
